154 related articles for article (PubMed ID: 36960615)
1. A computer program to assess the bone scan index for Tc-99m hydroxymethylene diphosphonate: evaluation of jaw pathologies of patients with bone metastases using SPECT/CT.
Ogawa R; Ogura I
Diagn Interv Radiol; 2023 Jan; 29(1):190-194. PubMed ID: 36960615
[TBL] [Abstract][Full Text] [Related]
2. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
Higashiyama S; Yoshida A; Kawabe J
Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
[TBL] [Abstract][Full Text] [Related]
3. Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
Higashiyama S; Yoshida A; Kawabe J
Urol Int; 2022; 106(9):963-969. PubMed ID: 35249033
[TBL] [Abstract][Full Text] [Related]
4. (89)Sr bremsstrahlung single photon emission computed tomography using a gamma camera for bone metastases.
Ota S; Uno M; Kato M; Ishiguro M; Natsume T; Kikukawa K; Tadokoro M; Ichihara T; Toyama H
Ann Nucl Med; 2014 Feb; 28(2):112-9. PubMed ID: 24297387
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of
Oya T; Ichikawa Y; Nakamura S; Tomita Y; Sasaki T; Inoue T; Sakuma H
Ann Nucl Med; 2023 Jun; 37(6):360-370. PubMed ID: 36947324
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
7. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison of
Zhang Y; Lin Z; Li T; Wei Y; Yu M; Ye L; Cai Y; Yang S; Zhang Y; Shi Y; Chen W
Sci Rep; 2022 Sep; 12(1):15993. PubMed ID: 36163353
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions.
Zhang Y; Shi H; Gu Y; Xiu Y; Li B; Zhu W; Chen S; Yu H
Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O
Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of Na[
Usmani S; Ahmed N; Gnanasegaran G; Al Kandari F; Marafi F; Bani-Mustafa A; Musbah A; Jassem Almashmoum M; Van den Wyngaert T
Acta Oncol; 2022 Oct; 61(10):1230-1239. PubMed ID: 35862646
[TBL] [Abstract][Full Text] [Related]
12. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients.
Motegi K; Miyaji N; Yamashita K; Koizumi M; Terauchi T
Ann Nucl Med; 2022 Sep; 36(9):834-841. PubMed ID: 35773557
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual Comparison of
Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
15. Quantitative
Coskun N; Cagdas B; Yildirim N
Hell J Nucl Med; 2022; 25(2):132-137. PubMed ID: 35913859
[TBL] [Abstract][Full Text] [Related]
16. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
17. New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT.
Ichikawa H; Shibutani T; Onoguchi M; Taniguchi Y
Ann Nucl Med; 2022 Nov; 36(11):941-950. PubMed ID: 36048347
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of mandibular invasion by head and neck cancers using 99mTc-methylene diphosphonate or 99mTc-hydroxymethylene diphosphonate and 201Tl chloride dual isotope single photon emission computed tomography.
Suzuki A; Togawa T; Kuyama J; Nakahara T; Kinoshita F; Takenouchi T; Harada H; Omura K
Ann Nucl Med; 2004 Jul; 18(5):399-408. PubMed ID: 15462402
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]